Paula M Meek1, Hans Petersen2, George R Washko3, Alejandro A Diaz3, Victor Klm4, Akshay Sood5, Yohannes Tesfaigzi6. 1. College of Nursing, University of Colorado-Denver, Denver, CO. 2. COPD Research Program, Lovelace Respiratory Research Institute, Albuquerque, NM. 3. Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 4. Temple University School of Medicine, Philadelphia, PA. 5. Department of Internal Medicine, University of New Mexico, Albuquerque, NM. 6. COPD Research Program, Lovelace Respiratory Research Institute, Albuquerque, NM. Electronic address: ytesfaig@lrri.org.
Abstract
BACKGROUND: COPD includes the chronic bronchitis (CB) and emphysema phenotypes. Although it is generally assumed that emphysema or chronic airflow obstruction (CAO) is associated with worse quality of life (QOL) than is CB, this assumption has not been tested. METHODS: The current study's analyses from the Lovelace Smokers' Cohort (LSC) were validated in the COPD Gene Cohort (COPDGene). CB without CAO (CB only) was defined as self-reported cough productive of phlegm for ≥ 3 mo/y for 2 consecutive years and postbronchodilator FEV1/FVC ≥ 70%. CAO without CB (CAO only) was defined as a postbronchodilator FEV1/FVC < 70% with no evidence of CB. QOL outcomes were obtained from the St. George's Respiratory Questionnaire (SGRQ) and the 36-Item Short Form Health Survey (SF-36) questionnaires. A priori covariates included age, sex, pack-years of smoking, current smoking, and FEV1. RESULTS: Smokers with CB without CAO (LSC = 341; COPDGene = 523) were younger and had a greater BMI and less smoking exposure than did those with CAO only (LSC = 302; COPDGene = 2,208). Compared with the latter group, QOL scores were worse for those with CB only. Despite similar SGRQ Activity and SF-36 Role Physical and Physical Functioning, SGRQ Symptoms and Impact scores and SF-36 emotional and social measures were worse in the CB-only group, in both cohorts. After adjustment for covariates, the CB-only group remained a significant predictor for "worse" symptoms and emotional and social measures. CONCLUSIONS: To our knowledge, this analysis is the first to suggest that among subjects with COPD, those with CB only present worse QOL symptoms and mental well-being than do those with CAO only.
BACKGROUND:COPD includes the chronic bronchitis (CB) and emphysema phenotypes. Although it is generally assumed that emphysema or chronic airflow obstruction (CAO) is associated with worse quality of life (QOL) than is CB, this assumption has not been tested. METHODS: The current study's analyses from the Lovelace Smokers' Cohort (LSC) were validated in the COPD Gene Cohort (COPDGene). CB without CAO (CB only) was defined as self-reported cough productive of phlegm for ≥ 3 mo/y for 2 consecutive years and postbronchodilator FEV1/FVC ≥ 70%. CAO without CB (CAO only) was defined as a postbronchodilator FEV1/FVC < 70% with no evidence of CB. QOL outcomes were obtained from the St. George's Respiratory Questionnaire (SGRQ) and the 36-Item Short Form Health Survey (SF-36) questionnaires. A priori covariates included age, sex, pack-years of smoking, current smoking, and FEV1. RESULTS: Smokers with CB without CAO (LSC = 341; COPDGene = 523) were younger and had a greater BMI and less smoking exposure than did those with CAO only (LSC = 302; COPDGene = 2,208). Compared with the latter group, QOL scores were worse for those with CB only. Despite similar SGRQ Activity and SF-36 Role Physical and Physical Functioning, SGRQ Symptoms and Impact scores and SF-36 emotional and social measures were worse in the CB-only group, in both cohorts. After adjustment for covariates, the CB-only group remained a significant predictor for "worse" symptoms and emotional and social measures. CONCLUSIONS: To our knowledge, this analysis is the first to suggest that among subjects with COPD, those with CB only present worse QOL symptoms and mental well-being than do those with CAO only.
Authors: Shannon Bruse; Akshay Sood; Hans Petersen; Yushi Liu; Shuguang Leng; Juan C Celedón; Frank Gilliland; Bartolomé Celli; Steven A Belinsky; Yohannes Tesfaigzi Journal: Am J Respir Crit Care Med Date: 2011-09-08 Impact factor: 21.405
Authors: Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin Journal: Am J Respir Crit Care Med Date: 2012-08-09 Impact factor: 21.405
Authors: Carlos H Martinez; Victor Kim; Yahong Chen; Ella A Kazerooni; Susan Murray; Gerard J Criner; Jeffrey L Curtis; Elizabeth A Regan; Emily Wan; Craig P Hersh; Edwin K Silverman; James D Crapo; Fernando J Martinez; Meilan K Han Journal: Respir Med Date: 2013-11-15 Impact factor: 3.415
Authors: D R Taylor; E D Bateman; L-P Boulet; H A Boushey; W W Busse; T B Casale; P Chanez; P L Enright; P G Gibson; J C de Jongste; H A M Kerstjens; S C Lazarus; M L Levy; P M O'Byrne; M R Partridge; I D Pavord; M R Sears; P J Sterk; S W Stoloff; S J Szefler; S D Sullivan; M D Thomas; S E Wenzel; H K Reddel Journal: Eur Respir J Date: 2008-09 Impact factor: 16.671
Authors: Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski Journal: Am J Respir Crit Care Med Date: 2007-05-16 Impact factor: 21.405
Authors: Victor Kim; Adam Davey; Alejandro P Comellas; Meilan K Han; George Washko; Carlos H Martinez; David Lynch; Jin Hwa Lee; Edwin K Silverman; James D Crapo; Barry J Make; Gerard J Criner Journal: Respir Res Date: 2014-04-27
Authors: Andrea S Oh; Matthew Strand; Katherine Pratte; Elizabeth A Regan; Stephen Humphries; James D Crapo; David A Lynch Journal: Radiology Date: 2020-07-07 Impact factor: 11.105
Authors: Surya P Bhatt; Sandeep Bodduluri; Abhilash S Kizhakke Puliyakote; Elizabeth C Oelsner; Arie Nakhmani; David A Lynch; Carla G Wilson; Spyridon Fortis; Victor Kim Journal: Thorax Date: 2021-01-06 Impact factor: 9.139
Authors: Filip Mejza; Louisa Gnatiuc; A Sonia Buist; William M Vollmer; Bernd Lamprecht; Daniel O Obaseki; Pawel Nastalek; Ewa Nizankowska-Mogilnicka; Peter G J Burney Journal: Eur Respir J Date: 2017-11-22 Impact factor: 16.671
Authors: André F S Amaral; Jaymini Patel; Bernet S Kato; Daniel O Obaseki; Hervé Lawin; Wan C Tan; Sanjay K Juvekar; Imed Harrabi; Michael Studnicka; Emiel F M Wouters; Li-Cher Loh; Eric D Bateman; Kevin Mortimer; A Sonia Buist; Peter G J Burney Journal: Am J Respir Crit Care Med Date: 2017-09-12 Impact factor: 21.405